Delivery Order SPE2DB20D1050-SPE2DB25FH82X
- Not listed
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $46,557.92 by the Defense Logistics Agency (DLA) on September 16, 2025, for the supply of Enbrel 50 mg/ml SureClick auto-injectors. This competitive award, which carries no set-aside designation, is structured as a firm fixed price delivery order with an ultimate completion date of September 17, 2025. The contract will be performed at...
- AmerisourceBergen Drug Corp was awarded a delivery order valued at $4,626.77 by the Defense Logistics Agency on April 23, 2025, for the supply of ENBREL 50 mg/mL SureClick auto-injectors. This is a firm fixed-price, non-set-aside contract with a completion date of April 24, 2025, and represents a child order under AmerisourceBergen's larger prime indefinite delivery contract with DLA Troop Support Medical. The product will be delivered to AmerisourceBergen's corporate office location in...
- AmerisourceBergen Drug Corp was awarded a delivery order by the Defense Logistics Agency valued at $74,662.13 for the supply of Enbrel 50 mg/ml SureClick auto-injectors. The contract, awarded on September 11, 2025, with an ultimate completion date of September 12, 2025, is structured as a firm fixed price delivery order with no set-aside designation. The pharmaceutical product will be delivered to the Conshohocken, Pennsylvania location, where AmerisourceBergen maintains its corporate office....
- AmerisourceBergen Drug Corp was awarded a delivery order valued at $24,505.16 by the Defense Logistics Agency (DLA) on September 5, 2025, for the supply of Enbrel 50 mg/mL SureClick auto-injectors. This is a firm fixed-price, non-set-aside contract with an ultimate completion date of September 8, 2025. The contract represents a delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a comprehensive pharmaceutical supply agreement...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on June 20, 2025, for the supply of ENBREL 50 mg/mL SureClick auto-injectors, valued at $4,626.77. This firm fixed-price delivery order, with an ultimate completion date of June 23, 2025, represents a small-value transaction under AmerisourceBergen's existing contract vehicle with DLA. The contract involves no set-aside designation, indicating it was competitively awarded. The pharmaceutical product will be...
- AmerisourceBergen Drug Corp has been awarded a $109,106.16 delivery order for Enbrel 50 mg/mL SureClick auto-injectors under a firm fixed price contract with the Defense Logistics Agency's Medical Supply Chain. The award, issued on May 7, 2025, with an ultimate completion date of May 8, 2025, represents a non-competed delivery order with no set-aside designation. The product will be delivered to the contractor's facility in Conshohocken, Pennsylvania, supporting federal medical supply...
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 7, 2025, for the supply of ENBREL 50 mg/mL SureClick auto-injectors, valued at $75,184.20. This firm fixed-price delivery order, with an ultimate completion date of August 8, 2025, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical. The award was competitively procured with no set-aside designation...
- AmerisourceBergen Drug Corp was awarded a $67,062.44 firm fixed-price delivery order by the Defense Logistics Agency's Medical Supply Chain on September 26, 2025, for the supply of Enbrel 50 mg/ml SureClick auto-injector pens. The contract, which is a child award under a larger indefinite delivery contract vehicle, carries an ultimate completion date of September 29, 2025, and was competitively awarded with no set-aside designation. Performance will be executed from the company's corporate...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $96,871.16 by the Defense Logistics Agency (DLA) on November 3, 2025, with an ultimate completion date of November 4, 2025. The award is for Enbrel 50 mg/mL SureClick auto-injector units and represents a firm fixed-price, competitively awarded contract with no set-aside designation. This delivery order is issued under AmerisourceBergen's existing...
- The Defense Logistics Agency awarded a $65,024.56 firm fixed price delivery order to AmerisourceBergen Drug Corp for ENBREL 50 mg/ml SureClick autoinjector pharmaceutical supplies on September 2, 2025, with an ultimate completion date of September 3, 2025. The contract involves no set-aside designation and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC)...
- SPE2DB20D1050Indefinite Delivery Contract
- SPE2DB20D1050-SPE2DB25FH82XDelivery Order
AmerisourceBergen Drug Corp was awarded a delivery order valued at $16,091.40 by the Defense Logistics Agency (DLA) on August 11, 2025, for the supply of Enbrel 50 mg/mL SureClick auto-injectors. The contract is a firm fixed price delivery order with an ultimate completion date of August 12, 2025, and represents performance at the vendor's location in Conshohocken, Pennsylvania. This award is a non-set-aside competitive award, reflecting AmerisourceBergen's capability to meet federal procurement requirements through open competition. The delivery order is issued as a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026, which serves as a comprehensive pharmaceutical support vehicle for military healthcare systems worldwide. AmerisourceBergen, a major pharmaceutical distributor and healthcare solutions provider, maintains a significant role in federal medical procurement through its DLA agreements. The broader IDC encompasses a wide range of pharmaceutical products and medical supplies, including specialty medications, generic and brand-name drugs, vaccines, and medical devices across multiple therapeutic domains, supporting the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. This Enbrel delivery order exemplifies the company's continued role in supplying critical pharmaceutical commodities to support military healthcare needs, with deliveries made on a firm fixed price basis to meet government medical supply requirements.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $16.1k | 8/11/25 |